Harbin Sermed is a Contract Research Organization (CRO) based in China, specializing in pharmaceutical R&D, clinical research, and drug registration services. The company focuses on providing efficient, high-quality, and low-risk clinical trial management, including monitoring, coordination with regulatory authorities, and trial planning to optimize costs for clients.
It operates as a subsidiary of Beijing Sermed Pharmaceutical Technology Development Co., Ltd. The company is recognized as a high-tech enterprise within the Chinese pharmaceutical service sector.
CLASSIFICATION
SIZE & FINANCIALS
Founded:2011
Ownership:subsidiary
Status:operating
0
CORPORATE STRUCTURE
Parent Company:Beijing Sermed Pharmaceutical Technology Development Co., Ltd.
COMPETITION
Position:Niche Player
LINKS
Website:hrbsermed.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Harbin Sermed Pharmaceutical Technology Development Co., Ltd. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Harbin Sermed Pharmaceutical Technology Development Co., Ltd.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.